Read + Share
Amedeo Smart
Independent Medical Education
Li W, Fang S, Cao Y, Wang Y, et al. A bifunctional fusion protein simultaneously targeting PD-L1 and TGF-beta1 (SHR1701) enhanced preclinical antitumor activity in oral squamous cell carcinoma. Oral Oncol 2026;180:108078.PMID: 42485683
Email
LinkedIn
Privacy Policy